Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer
Stephanie L. Graff, Fengting Yan, Yara Abdou
Topics & Concepts
MedicineTrastuzumabMetastatic breast cancerTaxaneOncologyLapatinibInternal medicineTrastuzumab emtansinePalbociclibBreast cancerAdverse effectCancerTargeted therapyPertuzumabHER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesCancer Treatment and Pharmacology